Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; JWH Compounds/Synthetic Cannabinoids;
應用:
JW 133-d5 is labelled JW 133 which is an intermediate used to synthesize potent CB2-Selective Cannabinoid Receptor Ligands such as 4-oxo-1,4-dihydroquinoline-3-carboxamides and 3-(1',1'-Dimethylbutyl)-1-deoxy-Δ8-THC analogs.